Sign inJoin free

Watch / Reporting Season

Stocks to watch ahead of US reporting season

12 July 20247:12

Stocks to watch ahead of US reporting season

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key points:

• Unfolding prevalence of a few dominant stocks in the US market

• Trends in sector-specific performances and high profitability sectors

• Gilead Sciences's performance and Talaria Capital's bottom-up approach.

Chad Padowitz from Talaria Capital highlights the recent trends in the US market. He observes the unexpectedly low inflation rate having an influence on bullish market conditions, particularly a shift from a few dominating stocks to a broader range including small-cap non-tech stocks. According to Chad, a notable aspect is an extreme valuation gap and sentiment that may not continue at the current level daily, but could indicate an ongoing trend in the market.

Chad elaborates on sector-specific performances, such as the communication services sector that shows a sharp contrast between overall and median growth rates. This, he states, could be a pattern of a winner-take-all scenario. He brings into focus the high profitability of the high performing sectors, existing primarily due to investors extrapolating recent high profitability for future cash flows.

Finally, Chad brings attention to the upcoming earnings season which could face challenges due to the high valuation on historically high profitability. He mentions Gilead Sciences (NASDAQ: GILD) as a company worth observing due to its steady performance and independent economic status. Chad concludes that Talaria Capital, as a value investor, maintains a bottom-up approach focusing on individual stocks rather than leaning too heavily on market events like the upcoming earnings season.

Full unedited transcript:

0:00

Let's now refocus on what we're seeing out of the States at the moment as earnings season for the second quarter gets underway. And also, we had a fascinating session overnight in the wake of that lower than expected inflation rate. Chad Pedowitz joining us from Capitol. Chad a very good morning to you. Can I first ask you about that. That session just gone off the back of that soft inflation read and that rotation into Smalls. How did you see it. Yeah. Well look it's come on the back of its exceptionally narrow bullish environment for a very small number of stocks that have dominated the index. So breadth has been exceptionally tight. So much so that last week only 1 in 6 companies outperformed the index. We obviously intuitively it should be around half that number you know three out of six. So coming into that it was it was primed for a rotation out and lower interest rates gave some respite to the

0:59

other sectors of the economy. Uh, which uh, allowed, uh, allowed money to move the other way in quite a rapid fashion. So it was definitely one of the largest, um, uh, relative gains between, you know, sort of small mid-cap non tech stocks versus tech stocks. Um, you know, the valuation gap is quite extreme at the moment. The sentiment is quite extreme. So, you know, while obviously that level of rotation on a daily basis, you know, won't won't be sustained. But but certainly the it's not impossible that, uh, that we could see the start of, uh, of something more like this going forward. So just in terms of the valuation of some of those sectors that we're seeing, Chad, um, I'll see you point out, for instance, the communication services sector is up around 31%. Median return of their stocks, though only 5%. Yeah. So look. Exactly. So with this communication sector, which obviously has

1:59

quite a few tech names or the tech sector itself, it's not just that the sectors themselves have been doing well relative to other sectors, which, you know, it's quite well known, but it's specifically only a couple of the winners, basically a winner take all. So as you mentioned, the the communications sector, while it's actually up 31%, the the median stocks are only up five. And in the tech sector it's at 35% up. But the median stock is only up 15. So it's a very, very narrow market which does dominate the index because these companies are such large market cap weightings, such that a night like last night, where the vast majority of shares actually went up, but the index, you know, the S&P, for instance, went down, you know, not quite 1%. The Nasdaq went down over 2%. So you know, so you are seeing that concentration, uh, show up. So as you point out that you're saying that those equities you're looking pretty expensive at this point because

2:59

investors are essentially capitalizing future cash flows by extrapolating those recent high profitability. I guess the question now is, as we head into earnings season, whether that's going to meet those that sort of anticipated the earnings forecasts.

3:17

Yeah. So what's what's happened over the last several years. And the forecasts are uh, are anticipating that to continue. Is that operating or Ebit margins have drifted up. So corporates have kept a greater share of revenue. And that has been a trend for some time. And it's actually at historically high levels. And when one looks at the valuation of the market, you're effectively paying very high valuation on what is historically high profitability. And not only is it currently high that profitability Ebit margins, but the forecasts from, you know, the analysts consensus is for that in 2026 to be basically 170 basis points or 1.7% higher than the ten year average. So so it's not just that it's a very high at the moment, the profitability, but the expectations high and the valuation of that is quite high, which we think put aside views on the economy and growth rates. Uh, you know, just aside all of that, that creates

4:17

a very high hurdle bar for the for the market to overcome. So overall then shed, what are you actually looking for in earnings season. What's going to be your focus. Yeah. Look we we not just to be clear we are we are a bottom up value investor with you know sort of a three year type holding period environment. So we don't focus too much on any one earnings season. We don't forecast any specific, uh, earnings outcomes on a quarterly basis. I just want to sort of be clear about that. But all I can say is the expectations for the market are about 8.5% year on year in this quarter and for the next three years, or, you know, on average over 10%. Um, so those are very high numbers given we are into a slower slowing economy, given there's a lot of indications at the market, That the economy is slowing. Even the CPI print, which we talked about, which you mentioned about earlier, you know, there's indicative of demand slowing. And it also leads to lower pricing power by

5:16

companies. Uh, all of that means that the hurdle bar is quite high. Uh, and I wouldn't be surprised if we do start seeing some relatively big earnings downgrades coming forward, whether that shows up in the current earnings season to start basically from today. Um, you know that that not sure about that, but I wouldn't be surprised if it does. Okay, Chad. So you talk about being bottom up. You do focus on individual stocks. One is Gilead Sciences. What are you liking about this one?

5:48

Yeah. Look from a whole different way of looking at it. So, uh, as a company, you know, they are a pharmaceutical company. They're, you know, the biggest franchise is HIV management and and even prevention hepatitis C. And they have, you know, some other things as well. There are about the company's market caps, around $90 billion. Um, they make about 9 billion profit. So sort of ten times earnings actually a bit lower, you know, to the Altos, uh, over a 4% dividend. So it's a very attractively priced company with a very long, uh,

6:22

a tail of, of existing drugs. And that's after spending about 6 billion a year on R&D. So you're, you're not paying much for the future delivery. And the market doesn't really give it much, uh, love let's call it that at the moment. Why? Because it's pretty much economically indifferent. It doesn't have the AI innovation excitement thing on the tech space. doesn't have the 3,040% growth rate you're seeing in some of the, you know, the Nvidia's of the world, and it doesn't have this cyclical element that if you're quite excited about the economy on, you know, sort of the banks or energy. So because of that we quite like it. The, the tougher economic environment, the tougher valuation environment, um, is not something that will negatively impact Hilliard. And you have a very strong valuation and free cash flow underpinning, uh, for it.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy